Affiliation:
1. Department of Pediatrics, Jewish Hospital and Medical Center of Brooklyn, Brooklyn, New York 11238
Abstract
Cefamandole, a new cephalosporin antibiotic, has greater activity against common pathogens, including
Escherichia coli, Haemophilus influenzae
, and
Proteus
(including indole-positive strains), than available cephalosporin drugs. We have evaluated the safety and pharmacokinetics of this drug in 30 infants and children. Blood levels and urinary excretion of the drug were similar to those previously found in adults. The only side effects were mild and transient elevation of serum glutamic oxalacetic transaminase in 12 patients and of blood urea nitrogen in 1 patient in whom serum creatinine remained normal and unchanged.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference15 articles.
1. Clinical and laboratory investigation of Cefamandole therapy of infection in infants and children;Azimi P. H.;J. Infect. Dis.,1978
2. Antibiotic susceptibility testing by a standard disc method;Bauer A. W.;Am. J. Clin. Pathol.,1966
3. Simplified, accurate method for antibiotic assay of clinical specimens;Bennett J. V.;Appl. Microbiol.,1966
4. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexins;Eykyn S.;Antimicrob. Agents Chemother.,1973
5. Clinical pharmacology of cefamandole compared with cephalothin;Fong I. W.;Antimicrob. Agents Chemother.,1976
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献